Children's Hospital of Philadelphia

Official Statements

Score contribution: 100 — 1 supporting sources.

Score 1001 references

Featured Reference

Expanded Access ProgramOpens in new window

“The Suzi and Scott Lustgarten Center for GI Motility at Children’s Hospital of Philadelphia (CHOP) offers cisapride and domperidone through expanded access programs.”

EAP Related Articles from Sponsor

Score contribution: 80 — 5 supporting sources.

Score 805 references

Featured Reference

18F-DOPA PET/CT scan for HyperinsulinismOpens in new window

Official title: Expanded Access Use of 18f-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects with Hyperinsulinemic Hypoglycemia - (NCT01916148)

Suzi and Scott Lustgarten Center for GI MotilitySource

- [Expanded Access Program](https://www.chop.edu/services/expanded-access-program)

Promising Use for Antibody Treatment for EoESource

At Children’s Hospital of Philadelphia, we’ve been using dupilumab to treat EoE for about 5 years — in some cases after traditional treatments have failed, and in others for compassionate use or to offer patients expanded treatment options.

Expanding Access to Omics-enabled Care in the CHOP ICUsSource

This initiative also successfully expanded access to rapid genome sequencing from 1% to 18% of critically ill infants.

CHOP Researchers Use Precision Medicine to Reverse Severe Lymphatic Disorder in a Patient with KLASource

Although that patient did not have KLA, the researchers felt the success of trametinib in treating his severe lymphatic symptoms, combined with Brenna’s rapidly deteriorating condition, warranted the request for expanded access to treat Brenna with the drug.